Beyin Tümörlerinde Acil Tedavi Yönetimi
Özet
Beyin tümörlerinde acil tedavi yönetimini ele alan bu makale, tümörlerin patofizyolojisi, klinik bulguları ve hayati önem taşıyan acil müdahale stratejilerini kapsamlı bir şekilde incelemektedir. Beyin tümörleri, kafa içi hacmin sınırlı olması nedeniyle hızla yaşamı tehdit eden durumlara yol açabilir; bu nedenle kafa içi basınç artışı sendromu (İKBAS), nöbetler (status epileptikus), beyin ödemi ve akut hidrosefali gibi komplikasyonların yönetimi kritiktir. Klinik tablo genellikle motor kayıplar, ataksi, afazi ve görme problemleri ile kendini gösterirken, erken teşhis için kontrastsız bilgisayarlı tomografi ilk adım olarak önerilmektedir. Tedavi protokolleri arasında agresif medikal müdahaleler (mannitol, deksametazon), solunum desteği, İKB monitörizasyonu ve dirençli vakalarda cerrahi bir seçenek olan dekompresif kranyektomi yer almaktadır. Makale, teknolojik ilerlemelere rağmen beyin tümörlerinde mortaliteyi azaltmanın yolunun, ikincil beyin hasarını önleyecek hızlı tanı ve doğru zamanlanmış cerrahi müdahaleden geçtiğini vurgulamaktadır.
This article, which examines emergency treatment management in brain tumors, comprehensively analyzes the pathophysiology, clinical findings, and vital emergency intervention strategies of tumors. Because brain tumors can rapidly lead to life-threatening conditions due to limited intracranial volume, the management of complications such as increased intracranial pressure syndrome (IIPS), seizures (status epilepticus), cerebral edema, and acute hydrocephalus is critical. While the clinical presentation often manifests with motor losses, ataxia, aphasia, and visual problems, non-contrast computed tomography is recommended as the first step for early diagnosis. Treatment protocols include aggressive medical interventions (mannitol, dexamethasone), respiratory support, ICP monitoring, and decompressive craniectomy, which is a surgical option in refractory cases. The article emphasizes that despite technological advances, the key to reducing mortality in brain tumors lies in rapid diagnosis and correctly timed surgical intervention to prevent secondary brain injury.
Referanslar
McKinney PA. Brain tumours: incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry. 2004;75 Suppl 2(Suppl 2):ii12-ii17. doi:10.1136/jnnp.2004.040741.
Nibhoria S, Tiwana KK, Phutela R et al. Histopathological Spectrum of Central Nervous System Tumors: A Single Centre Study of 100 Cases. Int J Sci Stud 2015;3(6):130-134.
Ostrom QT, Gittleman H, Fulop J et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 2015;17 Suppl 4: 41-462.
Robles P, Fiest KM, Frolkis AD, et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol. 2015 Jun;17(6):776-83. doi: 10.1093/neuonc/nou283.
Lacy J, Saadati H, Yu JB. Complications of brain tumors and their treatment. Hematol Oncol Clin North Am. 2012 Aug;26(4):779-96. doi: 10.1016/j.hoc.2012.04.007. Epub 2012 May 18.
Thomas RP, Iv M. (2015) Clinical features of brain tumors and complications of their treatment. ( Ed. Robert B. Daroff ), Bradley’s neurology in clinical practice. (1099-1104). Elsevier Health Sciences.
Yazol M, Öner AY. Beyin Gliomlarında Manyetik Rezonans Görüntüleme. TRD Sem 2016;4:20-36. doi: 10.5152/trs.2016.332.
Castillo LR, Robertson CS. Management of intracranial hypertension. Crit Care Clin 2007;22:713-32.
Marcus LP, McCutcheon BA, Noorbakhsh A et al. Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010). J Neurosurg. 2014 May;120(5):1201-11. doi: 10.3171/2014.1.JNS131264.
Arik Y, Leijten FS, Seute T et al. Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis. BMC Neurol. 2014 Jul 19;14:152. doi: 10.1186/1471-2377-14-152.
Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care. 2014 Jun;20(3):476-83. doi: 10.1007/s12028-013-9935-x.
Hocker SE. Status Epilepticus. Continuum (Minneap Minn). 2015 Oct;21(5 Neurocritical Care):1362-83. doi: 10.1212/CON.0000000000000225.
Wijdicks EF, Sheth KN, Carter BS, et al; American Heart Association Stroke Council Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Apr;45(4):1222-38. doi: 10.1161/01.str.0000441965.15164.d6.
Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001 Jun 26;56(12):1746-8. doi: 10.1212/wnl.56.12.1746.
Sunderland GJ, Jenkinson MD, Zakaria R. Surgical management of posterior fossa metastases. J Neurooncol. 2016 Dec;130(3):535-542. doi: 10.1007/s11060-016-2254-2. Epub 2016 Sep 12.
Muralidharan R. External ventricular drains: Management and complications. Surg Neurol Int. 2015 May 25;6(Suppl 6):S271-4. doi: 10.4103/2152-7806.157620.
Hutchinson PJ, Kolias AG, Timofeev IS et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016 Sep 22;375(12):1119-30. doi: 10.1056/NEJMoa1605215. Epub 2016 Sep 7.
Reithmeier T, Löhr M, Pakos P, et al. Relevance of ICP and ptiO2 for indication and timing of decompressive craniectomy in patients with malignant brain edema. Acta Neurochir (Wien). 2005 Sep;147(9):947-51; discussion 952. doi: 10.1007/s00701-005-0543-1. Epub 2005 Jun 3.
Bongiorni GT, Hockmuller MCJ, Klein C, et al. Decompressive craniotomy for the treatment of malignant infarction of the middle cerebral artery: mortality and outcome. Arq Neuropsiquiatr. 2017 Jul;75(7):424-428. doi: 10.1590/0004-282X20170053.
Emmez ÖH, Egemen E. Kafa içi basınç artışı tedavisinde pratik yaklaşımlar. Yoğun Bakım Dergisi 2010;9:77-84.
